MY190393A - Ophthalmic composition - Google Patents

Ophthalmic composition

Info

Publication number
MY190393A
MY190393A MYPI2017001274A MYPI2017001274A MY190393A MY 190393 A MY190393 A MY 190393A MY PI2017001274 A MYPI2017001274 A MY PI2017001274A MY PI2017001274 A MYPI2017001274 A MY PI2017001274A MY 190393 A MY190393 A MY 190393A
Authority
MY
Malaysia
Prior art keywords
ophthalmic composition
salt
hyaluronic acid
ophthalmic
chlorhexidines
Prior art date
Application number
MYPI2017001274A
Other languages
English (en)
Inventor
Takanori Ohno
Masahiro Kawahata
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of MY190393A publication Critical patent/MY190393A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MYPI2017001274A 2015-03-06 2016-03-04 Ophthalmic composition MY190393A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015045065 2015-03-06
PCT/JP2016/056861 WO2016143708A1 (ja) 2015-03-06 2016-03-04 眼科用組成物

Publications (1)

Publication Number Publication Date
MY190393A true MY190393A (en) 2022-04-20

Family

ID=56880167

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2017001274A MY190393A (en) 2015-03-06 2016-03-04 Ophthalmic composition

Country Status (7)

Country Link
JP (2) JP6716293B2 (zh)
KR (1) KR102607126B1 (zh)
MY (1) MY190393A (zh)
PH (1) PH12017501567A1 (zh)
SG (2) SG11201707117SA (zh)
TW (2) TW202114648A (zh)
WO (1) WO2016143708A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190068575A (ko) * 2016-10-14 2019-06-18 이콤 메디칼 게엠베하 안구 표면 항상성의 확립, 회복 및 보존 방법
WO2019112030A1 (ja) * 2017-12-08 2019-06-13 千寿製薬株式会社 水溶性高分子を含む水性液剤
TW202135822A (zh) * 2019-12-27 2021-10-01 日商樂敦製藥股份有限公司 水性組成物
CN112870216A (zh) * 2021-01-29 2021-06-01 张宽才 一种药物组合物及制剂和用途
JP2023022569A (ja) * 2021-08-03 2023-02-15 小林製薬株式会社 洗眼用組成物
CN114391550B (zh) * 2022-01-06 2022-11-22 江南大学 一种水溶性氯己定类抗菌剂及其制备方法和应用
WO2024135344A1 (ja) * 2022-12-21 2024-06-27 ライオン株式会社 眼科用製品

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1072376A (ja) * 1996-09-02 1998-03-17 Ofutekusu:Kk ヒアルロン酸含有点眼水溶液
JPH1160505A (ja) * 1997-05-20 1999-03-02 Senju Pharmaceut Co Ltd 防腐組成物
JPH115744A (ja) * 1997-06-16 1999-01-12 Toa Yakuhin Kk ヒアルロン酸含有の外用水溶液製剤
JP2002193815A (ja) * 2000-12-25 2002-07-10 Ophtecs Corp 眼手術用角膜乾燥防止点眼剤
JP2003002837A (ja) * 2001-06-21 2003-01-08 Lion Corp 水性外用剤組成物及び液体組成物の白濁防止方法
JP4431817B2 (ja) 2002-03-08 2010-03-17 第一三共株式会社 テトラゾール誘導体を含有する点眼剤
JP4694773B2 (ja) * 2003-06-06 2011-06-08 ロート製薬株式会社 粘膜適用液状組成物
BRPI0515191A (pt) * 2004-08-13 2008-07-08 Angiotech Internac Ag composição farmacêutica, método para aumentar osso ou substituir perda óssea, método para reduzir a dor associada com cicatriz pós-cirúrgica, método para prevenir aderência cirúrgicas, método para aumento ou reparo de pele ou tecido, método para manter volume em fluido ocular durante cirurgia ocular, método para reduzir a dor associada com osteoartrite, método para tratar doença de refluxo gastroesofágico, método para tratar ou prevenir incontinência urinária, método para tratar ou prevenir incontinência fecal, implante método e dispositivo médico
WO2008050776A1 (fr) 2006-10-26 2008-05-02 Senju Pharmaceutical Co., Ltd. Preparation liquide aqueuse ophtalmique
JP5595206B2 (ja) * 2009-09-30 2014-09-24 ロート製薬株式会社 眼科用液体組成物
TW201309306A (zh) * 2011-06-23 2013-03-01 參天製藥股份有限公司 含有玻尿酸或其鹽及丙二醇之點眼液

Also Published As

Publication number Publication date
JP6716293B2 (ja) 2020-07-01
JP2016166195A (ja) 2016-09-15
KR20170122773A (ko) 2017-11-06
TW201705948A (zh) 2017-02-16
SG11201707117SA (en) 2017-10-30
SG10201901426WA (en) 2019-03-28
TWI745287B (zh) 2021-11-11
WO2016143708A1 (ja) 2016-09-15
JP2020138979A (ja) 2020-09-03
PH12017501567A1 (en) 2018-02-05
KR102607126B1 (ko) 2023-11-27
TW202114648A (zh) 2021-04-16

Similar Documents

Publication Publication Date Title
MY190393A (en) Ophthalmic composition
WO2018195397A3 (en) Indole ahr inhibitors and uses thereof
MX2022005290A (es) Compuestos heterociclicos como inmunomoduladores.
SG10201908839QA (en) 2,4-dihydroxy-nicotinamides as apj agonists
MY196909A (en) Boronic acid derivatives and therapeutic uses thereof
AU2017228405A8 (en) Small molecule IRE1-alpha inhibitors
PH12017500367A1 (en) Compounds that inhibit mcl-1 protein
SG11201804121RA (en) Novel biphenyl compound or salt thereof
MX2018006207A (es) Compuestos heterociclicos como inmunomoduladores.
MX2018005292A (es) Inhibidores de acc y usos de los mismos.
AU2016278853A8 (en) Petrolatum-based compositions comprising cationic biocides
TN2017000524A1 (en) New bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them
MX2020006612A (es) Compuesto que funciona como inhibidor de proteína de bromodominio y composición.
TN2016000529A1 (en) Substituted dihydroisoquinolinone compounds
WO2016044463A3 (en) Mk2 inhibitors and uses thereof
MX2018010788A (es) Composicion oftalmologica.
MX2016015565A (es) Ciertos inhibidores de la proteina quinasa.
PH12017501539A1 (en) Disacetoxytubulysin h and analogs thereof
MX2017016517A (es) Composiciones estables al almacenamiento y metodos para el tratamiento de errores de refraccion del ojo.
MX2018003554A (es) Benzamidas sustituidas con isoxazolina y analogos como insecticidas.
MX2020001793A (es) Inhibidores del receptor de hidrocarburos de arilo (ahr) y usos de los mismos.
JOP20200323A1 (ar) طرق لتصنيع تركيبات الأحماض الأمينية
EP4364741A3 (en) Polymorphic form of tg02
CR20200275A (es) Hidroxiisoxazolinas y derivados de estos
WO2016176620A8 (en) Extracellular matrix compositions for the treatment of cancer or immunological diseases